v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net sales      
Net sales [1] $ 8,978 $ 10,878 $ 15,753
Cost of net sales      
Cost of net sales 7,927 7,972 11,363
Gross profit 1,051 2,906 4,390
Operating expenses:      
Selling, general and administrative [2] 4,964 5,152 5,318
Research and development 4,644 5,085 5,881
Total operating expenses 9,608 10,237 11,199
Operating loss (8,557) (7,331) (6,809)
Interest income 2,241 2,791 2,208
Other income (expense), net (including related parties amounts of nil, $32 and nil for the years ended December 31, 2025, 2024 and 2023, respectively) (12) 855 2,024
Loss before income taxes (6,328) (3,685) (2,577)
Income tax expense (1,622) (683) (1,274)
Net loss $ (7,950) $ (4,368) $ (3,851)
Net loss per share Basic $ (0.87) $ (0.48) $ (0.42)
Net loss per share Diluted $ (0.87) $ (0.48) $ (0.42)
Weighted average shares outstanding-Basic 9,190 9,150 9,113
Weighted average shares outstanding-Diluted 9,190 9,150 9,113
Net loss $ (7,950) $ (4,368) $ (3,851)
Other comprehensive loss, net of tax      
Net change in cumulative translation adjustment (891) (1,906) (2,527)
Comprehensive loss (8,841) (6,274) (6,378)
Products      
Net sales      
Net sales [1] 751 1,406 4,594
Cost of net sales      
Cost of net sales 1,401 1,223 3,666
Services      
Net sales      
Net sales [1] 8,227 9,472 11,159
Cost of net sales      
Cost of net sales $ 6,526 $ 6,749 $ 7,697
[1] Revenue recognized for the years ended December 31, 2025, 2024 and 2023 that was included in deferred revenue (including current and non-current) and customer advances as of the beginning of each year was $0.8 million, $0.1 million and $0.1 million, respectively.
[2] Allowances for credit loss of approximately $0.6 million, and reversals of credit losses of approximately $0.04 million and $1.3 million, were recognized as selling expenses in 2025, 2024 and 2023, respectively.